Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Worm, M.
Right arrow Articles by Henz, B.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Worm, M.
Right arrow Articles by Henz, B.M.
Related Collections
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 92 No. 5 (September 1), 1998: pp. 1713-1720

Retinoic Acid Inhibits CD40 + Interleukin-4-Mediated IgE Production In Vitro

M. Worm, J.M. Krah, R.A. Manz, and B.M. Henz

From the Department of Dermatology, Charité-Virchow Klinikum, Humboldt Universität and Deutsches Rheuma-Forschungszentrum, Berlin, Germany.

To elucidate the role of retinoic acid (RA) in anti-CD40 + interleukin-4 (IL-4)-mediated B-cell activation, the effect of 10-12 to 10-6 mol/L RA was studied in anti-CD40 (1 µg/mL) + IL-4 (5 ng/mL)-mediated proliferation and Ig synthesis by human peripheral blood mononuclear cells (PBMC) and B cells in healthy donors. Anti-CD40 + IL-4-mediated proliferation of PBMC and B cells was inhibited by RA in a dose-dependent manner, with maximal inhibition of 62% ± 5% in PBMC and 55% ± 4.4% in B cells by all-trans RA, and 58% ± 6.7% and 51% ± 4.7%, respectively by 13-cis RA. IgE synthesis was even more markedly inhibited by RA starting at concentrations of >10-14 mol/L for B cells and >10-10 mol/L for PBMC. Maximal inhibition of IgE production for B cells was at 10-8 mol/L for all-trans RA (94% ± 1.8%) and 96% ± 3.2% for 13-cis RA. Low concentrations of RA inhibiting IgE synthesis (10-10 mol/L) affected neither B-cell proliferation nor the production of IgA, IgG, and IgM. Elucidation of the mechanism involved in this inhibition of IgE production shows that epsilon germline transcription is decreased by RA, whereas production of interferon-gamma (IFN-gamma ) was not enhanced in the presence of RA. To differentiate whether the RA effect was mediated by RA receptors alpha , beta , and gamma , the expression of the retinoic acid receptors (RAR) was examined by reverse transcriptase-polymerase chain reaction (RT-PCR). The data show that unstimulated human peripheral B cells express mRNA of the RA receptor alpha , beta , and gamma . Using retinoids with different receptor binding specificity (CD336, CD437, CD2019, CD367), dose-dependent inhibition of IgE synthesis was shown by all four derivates, but was most marked by an RA binding the alpha receptor with high specificity. Taken together, this study shows that RA inhibits IgE production of anti-CD40 + IL-4-stimulated B cells in vitro.

© 1998 by The American Society of Hematology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
A. Ertesvag, H.-C. Aasheim, S. Naderi, and H. K. Blomhoff
Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK
Blood, May 1, 2007; 109(9): 3865 - 3872.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Dzhagalov, P. Chambon, and Y.-W. He
Regulation of CD8+ T Lymphocyte Effector Function and Macrophage Inflammatory Cytokine Production by Retinoic Acid Receptor {gamma}
J. Immunol., February 15, 2007; 178(4): 2113 - 2121.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J. O'Nions and M. J. Allday
Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein-Barr virus or T cell-derived mitogens
J. Gen. Virol., April 1, 2004; 85(4): 881 - 895.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
I. Junttila, R. P. Bourette, L. R. Rohrschneider, and O. Silvennoinen
M-CSF induced differentiation of myeloid precursor cells involves activation of PKC-{delta} and expression of Pkare
J. Leukoc. Biol., February 1, 2003; 73(2): 281 - 288.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Litterst and E. Pfitzner
An LXXLL Motif in the Transactivation Domain of STAT6 Mediates Recruitment of NCoA-1/SRC-1
J. Biol. Chem., September 20, 2002; 277(39): 36052 - 36060.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Kinoshita, K. Koike, H. H. Mwamtemi, S. Ito, S. Ishida, Y. Nakazawa, Y. Kurokawa, K. Sakashita, T. Higuchi, K. Takeuchi, et al.
Retinoic acid is a negative regulator for the differentiation of cord blood-derived human mast cell progenitors
Blood, May 1, 2000; 95(9): 2821 - 2828.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 1998 by American Society of Hematology         Online ISSN: 1528-0020